BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9684101)

  • 1. Gene therapy for malignant gliomas.
    Alavi JB; Eck SL
    Hematol Oncol Clin North Am; 1998 Jun; 12(3):617-29. PubMed ID: 9684101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy and targeted toxins for glioma.
    King GD; Curtin JF; Candolfi M; Kroeger K; Lowenstein PR; Castro MG
    Curr Gene Ther; 2005 Dec; 5(6):535-57. PubMed ID: 16457645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas.
    Shah AC; Benos D; Gillespie GY; Markert JM
    J Neurooncol; 2003 Dec; 65(3):203-26. PubMed ID: 14682372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients.
    Lowenstein PR; Castro MG
    Clin Immunol; 2018 Apr; 189():43-51. PubMed ID: 28720549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic viral therapy and immunotherapy of malignant brain tumors: two potential new approaches of translational research.
    Lou E
    Ann Med; 2004; 36(1):2-8. PubMed ID: 15000342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell-based immunotherapy for malignant gliomas.
    Akasaki Y; Black KL; Yu JS
    Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioma stem cell research for the development of immunotherapy.
    Xu Q; Yuan X; Yu JS
    Adv Exp Med Biol; 2012; 746():216-25. PubMed ID: 22639171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy of malignant glioma: recent advances in experimental and clinical studies.
    Sasaki M; Plate KH
    Ann Oncol; 1998 Nov; 9(11):1155-66. PubMed ID: 9862044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell- and peptide-based immunotherapeutic approaches for glioma.
    Yamanaka R
    Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma.
    Deng S; Zhu S; Qiao Y; Liu YJ; Chen W; Zhao G; Chen J
    Protein Cell; 2014 Dec; 5(12):899-911. PubMed ID: 25411122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular targeting for malignant gliomas (Review).
    Kondo Y; Hollingsworth EF; Kondo S
    Int J Oncol; 2004 May; 24(5):1101-9. PubMed ID: 15067331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FasL gene knock-down therapy enhances the antiglioma immune response.
    Jansen T; Tyler B; Mankowski JL; Recinos VR; Pradilla G; Legnani F; Laterra J; Olivi A
    Neuro Oncol; 2010 May; 12(5):482-9. PubMed ID: 20406899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single vs. combination immunotherapeutic strategies for glioma.
    Chandran M; Candolfi M; Shah D; Mineharu Y; Yadav VN; Koschmann C; Asad AS; Lowenstein PR; Castro MG
    Expert Opin Biol Ther; 2017 May; 17(5):543-554. PubMed ID: 28286975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental therapies: gene therapies and oncolytic viruses.
    Hulou MM; Cho CF; Chiocca EA; Bjerkvig R
    Handb Clin Neurol; 2016; 134():183-97. PubMed ID: 26948355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of malignant gliomas.
    Maleci A
    J Neurosurg Sci; 1989; 33(1):77-82. PubMed ID: 2674361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biology and gene therapy of glioma].
    Sanson M; Hoang-Xuan K
    Rev Prat; 1996 Feb; 46(4):464-8. PubMed ID: 8729353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting in gene therapy for gliomas.
    Fueyo J; Gomez-Manzano C; Yung WK; Kyritsis AP
    Arch Neurol; 1999 Apr; 56(4):445-8. PubMed ID: 10199333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of advances in molecular biology to the treatment of brain tumors.
    Takeshima H; Sawamura Y; Gilbert MR; Van Meir EG
    Curr Oncol Rep; 2000 Sep; 2(5):425-33. PubMed ID: 11122874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.
    Zhang Q; Xiang W; Yi DY; Xue BZ; Wen WW; Abdelmaksoud A; Xiong NX; Jiang XB; Zhao HY; Fu P
    Stem Cell Res Ther; 2018 Aug; 9(1):228. PubMed ID: 30143053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for high-grade glioma.
    Iwami K; Natsume A; Wakabayashi T
    Neurol Med Chir (Tokyo); 2010; 50(9):727-36. PubMed ID: 20885107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.